Dipeptide "alaptide" prevented impairments in spontaneous behavior produced with trimethyltin in male rats
Language English Country Sweden Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
19112412
PII: NEL290608A03
Knihovny.cz E-resources
- MeSH
- Behavior, Animal drug effects physiology MeSH
- Peptides, Cyclic administration & dosage pharmacology MeSH
- Rats MeSH
- Drug Interactions MeSH
- Random Allocation MeSH
- Statistics, Nonparametric MeSH
- Neuropeptides administration & dosage pharmacology MeSH
- Neuroprotective Agents administration & dosage MeSH
- Neurotoxins toxicity MeSH
- Exploratory Behavior drug effects physiology MeSH
- Motor Activity drug effects physiology MeSH
- Rats, Wistar MeSH
- Drug Administration Schedule MeSH
- Trimethyltin Compounds toxicity MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- cyclo(alanine-(1-amino-1-cyclopentane)carbonyl) MeSH Browser
- Peptides, Cyclic MeSH
- Neuropeptides MeSH
- Neuroprotective Agents MeSH
- Neurotoxins MeSH
- Trimethyltin Compounds MeSH
- trimethyltin MeSH Browser
OBJECTIVES: On the animal model of trimethyltin (TMT) induced behavioral deficits the effect of chronic treatment with spirocyclic dipeptide cyclo/alanyl-l-amino-l-cyclopentane-carbonyl (alaptide, AL) was evaluated in adult male rats. METHODS: Changes in the spontaneous behavioral repertoire were investigated in the open-field test on Day 21 (Session 1) and Day 28 (Session 2) after a single oral TMT administration. RESULTS: In Experiment 1, rats given the highest TMT dose (7.5 mg/kg) exhibited significantly increased total number of behavioral patterns, the floor sniffing being the most frequent pattern. While the medium TMT dose (5 mg/kg) had a similar effect only in Session 1, the lowest TMT dose (2.5 mg/kg) was entirely ineffective. In Experiment 2, an explicit beneficial influence of both AL doses (5 and 10 mg/kg) given for 10 days before and 10 days after TMT (7.5 mg/kg) on the spontaneous behavior repertoire was observed in both Session 1 and Session 2. The total number of patterns and the time spent in individual patterns of AL+TMT treated animals did not differ from the controls and those given AL alone. CONCLUSION: We conclude that sufficiently long AL treatment interfered with deleterious effects of TMT and forestalled changes in the structure and timing of spontaneous behavioral patterns. Thus, AL can be designated as a substance having "neuroprotective" effects.